1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/27342
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarper R.W.en
dc.contributor.authorPeverill R.E.en
dc.contributor.authorSmolich J.J.en
dc.date.accessioned2021-05-14T09:10:08Zen
dc.date.available2021-05-14T09:10:08Zen
dc.date.copyright1997en
dc.date.created19971104en
dc.date.issued2012-10-22en
dc.identifier.citationLancet. 350 (9085) (pp 1177-1178), 1997. Date of Publication: 1997.en
dc.identifier.issn0140-6736en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/27342en
dc.languageenen
dc.publisherElsevier Limited (32 Jamestown Road, London NW1 7BY, United Kingdom)en
dc.publisherElsevier B.V.en
dc.relation.ispartofThe Lanceten
dc.subjectacetylsalicylic acid/cm [Drug Comparison]en
dc.subjectacetylsalicylic acid/dt [Drug Therapy]en
dc.subjectanticoagulant agent/cb [Drug Combination]en
dc.subjectanticoagulant agent/cm [Drug Comparison]en
dc.subjectanticoagulant agent/do [Drug Dose]en
dc.subjectanticoagulant agent/dt [Drug Therapy]en
dc.subjectanticoagulant agent/pd [Pharmacology]en
dc.subjectblood clotting factor/ec [Endogenous Compound]en
dc.subjectblood clotting factor 7/ec [Endogenous Compound]en
dc.subjectprothrombin/ec [Endogenous Compound]en
dc.subject*thrombin/ec [Endogenous Compound]en
dc.subject*warfarin/ct [Clinical Trial]en
dc.subject*warfarin/cb [Drug Combination]en
dc.subject*warfarin/cm [Drug Comparison]en
dc.subject*warfarin/do [Drug Dose]en
dc.subject*warfarin/dt [Drug Therapy]en
dc.subject*warfarin/pd [Pharmacology]en
dc.subjectanticoagulant agent/ct [Clinical Trial]en
dc.subjectclinical trialen
dc.subjectcoronary artery bypass graften
dc.subjectheart infarctionen
dc.subjecthumanen
dc.subjectletteren
dc.subjectmethodologyen
dc.subjectpriority journalen
dc.subjectrecurrent diseaseen
dc.subjectsaphenous vein graften
dc.subjectstroke/co [Complication]en
dc.subjectstroke/dt [Drug Therapy]en
dc.subjectstroke/pc [Prevention]en
dc.subjectthrombin timeen
dc.subjectacetylsalicylic acid/ct [Clinical Trial]en
dc.subjectacetylsalicylic acid/cb [Drug Combination]en
dc.titleCARS trial: Warfarin and thrombin generation [15].en
dc.typeLetteren
dc.type.studyortrialOpinion, perspective or news-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/S0140-6736(05)63824-Xen
dc.identifier.doihttp://dx.doi.org/10.1016/S0140-6736%2805%2963824-Xen
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid9343528 [http://www.ncbi.nlm.nih.gov/pubmed/?term=9343528]en
dc.identifier.source27454031en
dc.identifier.institution(Peverill, Harper, Smolich) Cardiology Unit, Monash Medical Centre, Clayton, Vic. 3168, Australiaen
dc.description.addressR.E. Peverill, Cardiology Unit, Monash Medical Centre, Clayton, Vic. 3168, Australiaen
dc.subject.keywordheart infarctionen
dc.subject.keywordthrombin timeen
dc.subject.keywordstroke / complication / drug therapy / preventionen
dc.subject.keywordcoronary artery bypass graften
dc.subject.keywordsaphenous vein graften
dc.subject.keywordclinical trialen
dc.subject.keywordrecurrent diseaseen
dc.subject.keywordpriority journalen
dc.subject.keywordmethodologyen
dc.subject.keywordhumanen
dc.subject.keywordletteren
dc.relation.libraryurlLibKey Linken
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2021 Elsevier B.V., All rights reserved.en
dc.rights.statementCopyright 2012 Elsevier B.V., All rights reserved.en
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeLetter-
Appears in Collections:Articles
Show simple item record

Page view(s)

24
checked on Jun 27, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.